Intuitive Surgical (ISRG) Income from Non-Controlling Interests (2017 - 2026)

Intuitive Surgical's (ISRG) quarterly Income from Non-Controlling Interests came in at -$18.7 million in Q2 2026, down 422.41% year-on-year from $5.8 million in Q2 2025, and up 20.76% quarter-over-quarter from -$23.6 million in Q1 2026.

Intuitive Surgical (ISRG) Income from Non-Controlling Interests (2017 - 2026) Analysis & Trends

Intuitive Surgical's Income from Non-Controlling Interests history runs 10 years deep, the most recent figure standing at -$18.7 million for Q2 2026.

  • On a quarterly basis, Income from Non-Controlling Interests fell 422.41% year-over-year to -$18.7 million in Q2 2026; TTM through Jun 2026 was -$58.4 million, a 335.48% decrease from a year earlier, with the FY2025 full-year figure at $20.6 million, up 38.26% from the prior year.
  • Income from Non-Controlling Interests grew to -$18.7 million in Q2 2026 per ISRG's latest filing, from -$23.6 million in the prior quarter.
  • Across five years, Income from Non-Controlling Interests topped out at $59.5 million in Q3 2024 and bottomed at -$90.7 million in Q1 2022.
  • The 5-year median for Income from Non-Controlling Interests is $4.1 million (2023), against an average of -$6.9 million.
  • Biggest YoY gain for Income from Non-Controlling Interests was 1351.22% in 2024; the steepest drop was 1120.0% in 2024.
  • Year by year, Income from Non-Controlling Interests stood at $13.9 million in 2022, then plunged by 67.63% to $4.5 million in 2023, then tumbled by 1120.0% to -$45.9 million in 2024, then surged by 54.03% to -$21.1 million in 2025, then grew by 11.37% to -$18.7 million in 2026.
  • Per Business Quant, the three latest ISRG Income from Non-Controlling Interests figures stand at -$18.7 million (Q2 2026), -$23.6 million (Q1 2026), and -$21.1 million (Q4 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Inc. Minority (Qtr)
1 Intuitive Surgical 126.93 Bn 121.71 Bn 1.96 Bn -18.70 Mn
2 Becton Dickinson 44.94 Bn 44.13 Bn 2.15 Bn -
3 Alcon 33.13 Bn 31.47 Bn 1.53 Bn -
4 Medline 32.87 Bn 30.63 Bn 1.84 Bn 110.00 Mn
5 Resmed 29.48 Bn 27.82 Bn 890.98 Mn -
6 West Pharmaceutical Services 23.28 Bn 22.84 Bn 329.20 Mn -
7 Solventum 14.11 Bn 13.55 Bn 1.10 Bn -
8 Cooper Companies 13.80 Bn 13.66 Bn 735.40 Mn -
9 Align Technology 12.06 Bn 11.00 Bn 736.59 Mn -
10 Baxter International 11.95 Bn 9.93 Bn 891.00 Mn -

Historic Data

Download Data
DateValue
Jun 30, 2026 -18.70 Mn
Mar 31, 2026 -23.60 Mn
Dec 31, 2025 -21.10 Mn
Sep 30, 2025 5.00 Mn
Jun 30, 2025 5.80 Mn
Mar 31, 2025 5.40 Mn
Dec 31, 2024 -45.90 Mn
Sep 30, 2024 59.50 Mn
Jun 30, 2024 4.60 Mn
Mar 31, 2024 -4.20 Mn
Dec 31, 2023 4.50 Mn
Sep 30, 2023 4.10 Mn
Jun 30, 2023 4.10 Mn
Mar 31, 2023 5.50 Mn
Dec 31, 2022 13.90 Mn
Sep 30, 2022 700,000.00
Jun 30, 2022 -33.40 Mn
Mar 31, 2022 -90.70 Mn
Dec 31, 2021 2.50 Mn
Sep 30, 2021 6.60 Mn